Shared Decision-Making in Hematologic Malignancies

Video

In this video we discuss the goals of shared-decision making in hematologic malignancies and touch upon different scenarios where its use may be appropriate.

In this video, Thomas W. LeBlanc, MD, MA, of the Duke Cancer Institute in Durham, North Carolina, discusses the goals of shared-decision making when treating patients with hematologic malignancies and touches upon different scenarios where its use may be appropriate.

Dr. LeBlanc gave a presentation on this topic at the 11th Annual National Comprehensive Cancer Network (NCCN) Hematologic Malignancies Congress, held September 1–October 1 in New York.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
More follow-up data will better elucidate the impact of frontline use of hypomethylating agents in patients with myelodysplastic syndromes.
Greater direct access to academic oncologists may help address challenges associated with a lack of CAR T education in the community setting.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.